Obesity
📧 Sign up to get email alerts when something new happens for Obesity.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-01-19Clinical Trial Update: A Study of Tirzepatide (LY3298176) in Chinese Participants Without Type 2 Diabetes Who Have Obesity or Overweight (SURMOUNT-CN) [Phase 3]
Phase 3 SURMOUNT-CN trial in Chinese participants without type 2 diabetes evaluated tirzepatide for obesity/overweight; study completed with…
-
CLINICAL_TRIALS trial_result · 2024-01-19Clinical Trial Update: Utilizing Protein During Weight Loss to Impact Physical Function and Bone [NA]
A completed clinical trial investigating the role of a protein during weight loss and its impact on physical function and bone health.
-
CLINICAL_TRIALS trial_result · 2024-01-18Clinical Trial Update: Liraglutide Effectiveness in Preoperative Weight-loss for Bariatric-metabolic Surgery [Phase 4]
Phase 4 trial update evaluating liraglutide effectiveness for preoperative weight loss in bariatric-metabolic surgery candidates.
-
CLINICAL_TRIALS trial_result · 2024-01-17Clinical Trial Update: Amlexanox for Type 2 Diabetes and Obesity [Phase 2]
Phase 2 trial of amlexanox for type 2 diabetes mellitus and obesity was terminated, with results posted.
-
CLINICAL_TRIALS trial_result · 2024-01-08Clinical Trial Update: A Study to Measure Stomach Emptying in Overweight Non-diabetic and Diabetic Participants Using Tirzepatide [Phase 1]
Phase 1 study evaluating the effect of tirzepatide on stomach emptying in overweight/obese individuals, including participants with Type 2 d…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-01-05Clinical Trial Update: SGLT2 Inhibition in Older Obese Adults With Pre-diabetes [Phase 1, Phase 2]
Clinical trial update on SGLT2 inhibition in older obese adults with pre-diabetes across Phase 1 and Phase 2; results posted, completion sta…
-
CLINICAL_TRIALS research · 2023-12-20Clinical Trial Update: Online Food and Beverage Labels and Vending Machine Selections [NA]
A completed clinical trial by the University of Pennsylvania evaluating online food and beverage labels and vending machine selections, with…
-
CLINICAL_TRIALS trial_result · 2023-12-18Clinical Trial Update: Bioenergetic Effects of Aging and Menopause (BEAM) [Phase 4]
Phase 4 clinical trial update on bioenergetic effects of aging and menopause (BEAM) investigating menopause- and obesity-related outcomes.
-
CLINICAL_TRIALS trial_result · 2023-12-15Clinical Trial Update: Metabolic Effects of Natriuretic Peptide Hormones [Phase 4]
Phase 4 trial evaluating metabolic effects of natriuretic peptide hormones was terminated, with results posted in December 2023.
-
CLINICAL_TRIALS trial_result · 2023-12-14Clinical Trial Update: Orlistat Reduces Uric Acid in Overweight/Obese Patients With Hyperuricemia [Phase 4]
Phase 4 trial reporting that orlistat reduces uric acid in overweight/obese patients with hyperuricemia.
-
CLINICAL_TRIALS trial_result · 2023-12-11Clinical Trial Update: Physical Activity Choices Everyday [NA]
Clinical trial update reporting completion and posted results for a study on physical activity choices in obesity.
-
CLINICAL_TRIALS trial_result · 2023-12-08Clinical Trial Update: Peer Navigators to Address Obesity-Related Concerns for African Americans With Serious Mental Illness [NA]
A completed clinical trial evaluating peer navigators to address obesity-related concerns in African Americans with serious mental illness.
-
CLINICAL_TRIALS research · 2023-12-04Clinical Trial Update: The Effect of GLP-1 Agonists Versus OCs on Reproductive Disorders and Cardiovascular Risks in Overweight PCOS [Phase 4]
Phase 4 trial evaluating GLP-1 agonists versus oral contraceptives on reproductive disorders and cardiovascular risks in overweight individu…
-
CLINICAL_TRIALS trial_result · 2023-12-04Clinical Trial Update: Active You: A Novel Exercise Program for African Americans [NA]
Completed clinical trial update for Active You, a novel exercise program for African Americans, with results posted.
-
CLINICAL_TRIALS trial_result · 2023-12-01Clinical Trial Update: Study To Evaluate The Effect Of Two Steady State Doses of PF 06882961 On Rosuvastatin And Midazolam Pharmacokinetics In Otherwise Healthy Adult Participants With Obesity [Phase 1]
Phase 1 trial evaluating steady-state dosing of PF 06882961 on pharmacokinetics of rosuvastatin and midazolam in adults with obesity; study …
-
CLINICAL_TRIALS trial_result · 2023-12-01Clinical Trial Update: Intermittent Fasting Adherence and Self Tracking [NA]
A completed clinical trial evaluating intermittent fasting adherence and self-tracking in adults with hypertension and obesity. Results post…
-
FDA approval · 2023-11-30FDA Approved: CONTRAVE EXTENDED-RELEASE — Supplemental Application (Nalpropion Pharmaceuticals LLC)
FDA approved a supplemental application to authorize an extended-release formulation of CONTRAVE (naltrexone hydrochloride and bupropion hyd…
-
FDA approval · 2023-11-15FDA Approved: IMCIVREE — Supplemental Application (Rhythm Pharmaceuticals, Inc)
The FDA approved a supplemental application for IMCIVREE (setmelanotide) submitted by Rhythm Pharmaceuticals, Inc.
-
CLINICAL_TRIALS trial_result · 2023-11-14Clinical Trial Update: Effect of Biktarvy & Symtuza on microRNAs in HIV and Correlation With Weight Gain [Phase 4]
Phase 4 clinical trial examining the effect of Biktarvy and Symtuza on microRNAs in HIV and its correlation with weight gain.
-
CLINICAL_TRIALS trial_result · 2023-11-13Clinical Trial Update: Weight Regain Treatment Post-Bariatric Surgery [Phase 2, Phase 3]
A Phase 2/3 clinical trial update on treatments for weight regain after bariatric surgery has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2023-11-09Clinical Trial Update: Sympathetic Activation in Obesity [NA]
A completed clinical trial from Yale University investigating sympathetic activation in individuals with obesity and healthy controls; resul…
-
FDA approval · 2023-11-08FDA Approved: ZEPBOUND — Original Application (Eli Lilly and Company)
The FDA approved ZEPBOUND (tirzepatide) from Eli Lilly through an original application for obesity/weight management in adults. This marks t…
-
CLINICAL_TRIALS trial_result · 2023-11-07Clinical Trial Update: A Study of HS-20094 Evaluating Weight Loss in Obese and Overweight Chinese Subjects [Phase 2]
Phase 2 clinical trial update for HS-20094 evaluating weight loss in overweight and obese Chinese subjects; current status is unknown.
-
CLINICAL_TRIALS trial_result · 2023-11-07Clinical Trial Update: tDCS for Impulsivity and Compulsivity in Obesity [NA]
A completed clinical trial investigating transcranial direct current stimulation (tDCS) for impulsivity and compulsive overeating in obesity…
-
CLINICAL_TRIALS research · 2023-11-07Clinical Trial Update: Cognitive Aspects of Response to Treatment for Weight-related Health to Improve Eating and Exercise Earlier in Life [NA]
A completed clinical trial on cognitive aspects of treatment response for weight-related health in youth, investigating how executive functi…